JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Acne

Including

Acne rosacea.

Definition

With regard to drug treatment:
Topical:
Applied to the skin only.

Systemic:
Taken by mouth or other routes so that it has an affect on the whole body.

Obligatory

Must not donate if:
a) Has ever taken etretinate (Tigason®).

b) Less than 24 months from the last dose of acitretin (Neotigason®).

c) Less than four weeks from the last dose of isotretinoin (Roaccutane®).

d) There is secondary infection.

e) Less than seven days from completing systemic antibiotic treatment for secondary infection.

Discretionary

If using topical treatments (including retinoids), or taking oral antibiotics, diuretics (such as spironolactone) or oral co-cyprindiol (Dianette® (cyproterone acetate and ethinylestradiol)), accept.

 

Additional Information

Etretinate (Tigason®), acitretin (Neotigason®) and isotretinoin (Roaccutane®) taken systemically can cause birth defects in babies exposed to them while inside the womb. It is important to allow time for the drug to be cleared from the blood of a donor. It takes longer to clear some drugs than others. There is no published data that topical retinoids cause birth defects.

Secondary infection of acne is usually obvious with swelling and redness of affected spots. There is a risk of bacteria entering the blood. This could be a serious threat to anybody receiving blood or blood components. This is because bacteria can multiply to dangerous levels after collection.

Reason for change

The allowed medication for acne has been updated.

Donor Information

If you wish to obtain more information regarding a personal medical issue please contact your National Help Line.

Please do not contact this web site for personal medical queries, as we are not in a position to provide individual answers.

Update Information

This entry was last updated in:
DSG-WB Edition 203, Release 33.